1. Home
  2. TEX vs PTGX Comparison

TEX vs PTGX Comparison

Compare TEX & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Terex Corporation

TEX

Terex Corporation

HOLD

Current Price

$63.89

Market Cap

7.3B

Sector

Industrials

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$110.08

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TEX
PTGX
Founded
1933
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
6.4B
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
TEX
PTGX
Price
$63.89
$110.08
Analyst Decision
Buy
Strong Buy
Analyst Count
10
13
Target Price
$68.80
$108.23
AVG Volume (30 Days)
1.0M
507.7K
Earning Date
05-01-2026
05-07-2026
Dividend Yield
1.12%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
$5,421,000,000.00
N/A
Revenue This Year
$47.67
$874.25
Revenue Next Year
$6.66
N/A
P/E Ratio
N/A
$2,195.80
Revenue Growth
5.73
N/A
52 Week Low
$41.70
$49.86
52 Week High
$71.50
$111.45

Technical Indicators

Market Signals
Indicator
TEX
PTGX
Relative Strength Index (RSI) 56.61 61.85
Support Level $58.36 $94.48
Resistance Level $65.64 N/A
Average True Range (ATR) 2.45 4.80
MACD 0.44 1.33
Stochastic Oscillator 80.34 90.91

Price Performance

Historical Comparison
TEX
PTGX

About TEX Terex Corporation

Terex is a global manufacturer of aerial work platforms, materials processing equipment, and specialty equipment for the waste, recycling, and utility industries. Its current composition is a result of numerous acquisitions over several decades to focus on a smaller group of light construction and other vocational equipment, having divested a handful of underperforming businesses, particularly in cranes and other lifting equipment. These remaining segments see heavy demand in nonresidential construction (aerial work platforms—40% sales), aggregates/mining (materials processing—30% sales), environmental, waste/recycling and utilities (environmental solutions group—30% sales).

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: